Clinical Research Directory
Browse clinical research sites, groups, and studies.
Research on the Use of Probiotics in the Prevention and Treatment of Inflammatory Bowel Disease
Sponsor: Wecare Probiotics Co., Ltd.
Summary
This project involves the use of oral Lactobacillus reuteri as an adjunct therapy for 8 weeks. Endoscopic observation of intestinal inflammation will be conducted at 1 month, 3 months, 6 months, and 12 months after the administration of the drug. Intestinal fluid will be collected endoscopically for 16S RNA analysis to assess changes in the gut microbiota. Inflammatory changes in the patients will be detected through peripheral blood tests, and fecal calprotectin levels will be measured to evaluate the progression of the disease.
Official title: Application Research of Lactobacillus Reuteri in the Treatment of Inflammatory Bowel
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2025-01-01
Completion Date
2025-12-30
Last Updated
2025-04-04
Healthy Volunteers
No
Conditions
Interventions
Probiotic
The experimental phase of the study lasts 8 weeks and each patient will be visited 4 times (January, March, June, and December).
Maltodextrin
The experimental phase of this study had last 8 weeks and each patient will make 4 visits (January, March, June, and December).
Locations (1)
Gastroenterology Department of Jiangsu Province （Suqian）Hospital
Suqian, Jiangsu, China